GS-100 inonzi recombinant AAV9 vector inonyora gene revanhu NGLY1. Yakagamuchira zita rekuti orphan drug kubva kuUS Food and Drug Administration uye European Medicine Agency (EMA) Kurapa uku kwakawanawo zita reFDA rechirwere chevana chisingawanzoitika muna 2021 uye zita rekukurumidza gore rapfuura.
#SCIENCE #Shona #CU
Read more at Clinical Trials Arena